AGIOS PHARMACEUTICALS, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2011 to 2023.
  • Agios Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $948M.
  • Agios Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $674M.
  • Agios Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$352M, a 51.9% decline from 2022.
  • Agios Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$232M, a 114% decline from 2021.
  • Agios Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $1.6B.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$352M -$120M -51.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 -$232M -$1.84B -114% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $1.6B +$1.93B Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 -$327M +$84.1M +20.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$411M -$65.4M -18.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$346M -$31.4M -9.97% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$315M -$116M -58.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
2016 -$198M -$80.7M -68.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
2015 -$118M -$64.2M -120% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-14
2014 -$53.5M -$14.1M -35.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-16
2013 -$39.4M -$19.3M -96% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 -$20.1M +$3.6M +15.2% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-24
2011 -$23.7M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.